Publications & Posters

Publications & Posters

Journal of Alzheimer’s Disease | April 08, 2018
This study Investigates the association of plasma NFL with preclinical-AD features, such as high neocortical amyloid-β load (NAL) and subjective memory complaints, and cognitive performance in cognitively normal older adults.
Alzheimer's & Dimentia | April 04, 2018
The goals of the present study using a novel assay for pTau were to examine and compare levels of plasma phospho-tau181 (pTau181) and plasma total tau by clinical diagnosis across the AD spectrum
Multiple Sclerosis Journal | March 17, 2018
The objective of the study was to investigate the association between sNfL and clinical and MRI measurements in a therapy-naive cohort of CIS and RRMS patients in the very early stage of disease.
PLOS One | March 08, 2018
The three methods tested allow sensitive detection of GAD65, but SIMOA appears best suited for automated quantification of subpicomolar concentrations.
Journal of Neurology, Neurosurgery & Psychiatry | March 06, 2018
 A blood-based biomarker of neuronal damage in sporadic Creutzfeldt-Jakob disease (sCJD) will be extremely valuable for both clinical practice and research aiming to develop effective therapies.
Journal of Neurology, Neurosurgery & Psychiatry | February 13, 2018
This study used an ultrasensitive single molecule methodology to measure plasma tau concentrations in 176 participants: 71 with bvFTD, 83 with PPA and 22 healthy controls.
The Journal of Translational Immunology | February 12, 2018
The objective of this study was to examine the assay formats used to detect anti-drug antibodies (ADA) in clinical studies of the anti-TNF monoclonal antibodies adalimumab and infliximab in chronic inflammatory disease and their potential impact on pharmacokinetic and clinical outcomes.
Analytical Chemistry | February 09, 2018
This report describes a novel method for isolating and detecting individual enzyme molecules using polymer arrays of picoliter microwells.
Journal of Neurotrauma | February 07, 2018
The primary aim of this study was to examine the effects of valproic acid (VPA) treatment on serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NF-L) levels.
February 03, 2018
Type 2 diabetes and obesity are pro-inflammatory states associated with increased risk of cardiovascular disease.